Visium Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Visium Asset Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,833	Closed	-$10M	–	1233
2015 Q2	$10M	Buy	15,833 +1,547	+11%	+$822K	0.14%	155
2015 Q1	$7.35M	Buy	14,286 +7,008	+96%	+$3.54M	0.11%	192
2014 Q4	$3.9M	Sell	7,278 -12,217	-63%	-$5.5M	0.06%	304
2014 Q3	$29.2M	Sell	19,495 -2,061	-10%	-$2.98M	0.48%	39
2014 Q2	$29.5M	Hold	21,556	–	–	0.46%	37
2014 Q1	$29.9M	Buy	21,556 +1,906	+10%	+$2.22M	0.51%	41
2013 Q4	$19.6M	Sell	19,650 -6	-0%	-$6.2K	0.38%	55
2013 Q3	$20.5M	Buy	19,656 +260	+1%	+$278K	0.49%	51
2013 Q2	$21.2M	Buy	+19,396	New	+$21.6M	0.54%	42

Other funds holding VIRX

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return